PHR
PHARMENA
GPW
LISTED
Finance
BETA 1 report| H1 2026 | |
|---|---|
| Revenue | 663 k PLN |
| EBITDA | -1,528 k PLN |
| Net income | -1,477 k PLN |
| Gross margin | 82.35% |
We have data for 1 period. The chart will appear once the next report is published. Next report expected November 27, 2026.